A team of Western researchers has developed a simple test—faster and more accurate than any approved thus far in Canada—to determine who has developed COVID-19 antibodies.
Jan 18, 2021
0
7
(HealthDay)—Sex, age, and severity of disease can predict increased antibody response in COVID-19 survivors, according to a study published recently in the Journal of Clinical Investigation.
Oct 26, 2020
0
3
SARS-CoV-2, the virus responsible for COVID-19, can cause a wide range of symptoms, from none at all to severe respiratory stress, multi-organ failure and death. The virus notably targets the lungs, but many patients also ...
Sep 9, 2020
1
2
A new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, ...
Apr 23, 2020
0
29
Scientists at UCL have invented a new test to identify the earliest genetic changes of prostate cancer in blood: a process which could allow doctors to see if cancers have spread, monitor tumour behaviour and enable better ...
Mar 9, 2020
0
149
In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer's disease—up to 14 years before a clinical diagnosis is made. Amyloid-β folding ...
Oct 16, 2019
0
7
Random plasma glucose tests could be used to predict which patients will develop diabetes, according to a study of Veterans Affairs treatment data. Researchers from several VA systems showed that levels of glucose found during ...
Jul 19, 2019
0
7
An investigational test that screens for colorectal cancer could detect genetic mutations that are indicative of the disease with a high degree of sensitivity and specificity, according to results of a study presented at ...
Oct 30, 2017
0
0
(HealthDay)—Analysis of Epstein-Barr virus (EBV) DNA in plasma samples can identify early asymptomatic nasopharyngeal carcinoma, according to a study published in the Aug. 10 issue of the New England Journal of Medicine.
Aug 10, 2017
0
38
(HealthDay)—One measurement of plasma glycated CD59 (pGCD59) in pregnancy can predict glucose intolerance, according to a study published online May 3 in Diabetes Care.
May 11, 2017
0
1
